scripclinicalresearch.com Report : Visit Site

Technical data of the scripclinicalresearch.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host scripclinicalresearch.com. Currently, hosted in United Kingdom and its service provider is Safenames Ltd. .

the related websites

shlegal.com urlm.co.uk riskdecisions.com zoominfo.com scripintelligence.com clinica.co.uk manchestereveningnews.co.uk uk.sports.yahoo.com theinquirer.net bbc.co.uk thesun.co.uk ft.com thetimes.co.uk 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

skip to main content close icon we use cookies to improve your website experience. to learn about our use of cookies and how you can manage your cookie settings, please see our cookie policy . by continuing to use the website, you consent to our use of cookies. pharma intelligence is part of the business intelligence division of informa plc informa plc about us investor relations talent this is operated by a business or businesses owned by informa plc and all copyright resides with them. informa plc's registered office is 5 howick place, london sw1p 1wg. registered in england and wales. number 8860726. menu menu menu search icon pharma report store recommendations product login how we help products & services resource hub events, awards & webinars about contact pharma report store recommendations product login search search icon left arrow icon close icon how we help clinical research and development intelligence ​competitive and market intelligence business development and licensing business and portfolio strategy ​regulatory approval medtech market intelligence who we help pharmaceutical companies ​contract research organizations consultancies​ ​marketing agencies ​medtech close icon types: products: news and insights in vivo medtech insight pink sheet rose sheet scrip data and analytics sitetrove chinatrove trialtrove pharmaprojects datamonitor healthcare biomedtracker medtrack rxscorecard strategic transactions meddevicetracker pharmapremia marketing services awareness lead generation our popular solutions thought leadership network in person skipta marketing services consulting pharma consulting close icon hot topics brexit cell and gene therapy clinical trial optimization deal trends fda immuno-oncology medtech personalized medicine reimbursement thought leadership analyst opinion analysis articles blog case studies podcasts reports videos infographics white papers press releases research and development strategy clinical and research excellence index the future of personalized medicine close icon events conferences 2018 awards care awards 2018 global generics & biosimilars awards 2018 scrip awards 2018 medtech insight awards 2018 care awards 2017 upcoming webinars webinar recordings close icon about us media center meet the team our offices close icon global search configuration search site products & services close icon search by keyword go focus business development and licensing regulatory approval medtech market intelligence clinical research and development intelligence business and portfolio strategy competitive and market intelligence pharma consulting marketing services needs go scrip: industry news and insights from licensing to clinical trials to competitor activity, stay current on business developments in your market. understand what’s happening in the market right now and what it means for the future of your business with news and insight from our team of journalists and analysts. scrip is essential for anyone making commercial decisions in the pharmaceutical industry. request a free trial product login follow market developments go beyond the news hear from news makers sections free resources headlines product details how we help what's included meet the team testimonials customers request a trial related products related services ​go behind the headlines with exclusive access to key industry decision makers and best-in-class proprietary data, scrip empowers you to understand the news behind the news. how it helps use scrip’s focus on the strategic implications of global pharma news to fully understand what worldwide developments in the industry mean for your business. with end-to-end coverage encompassing the whole of the drug discovery, development, and product life cycle value chain, scrip delivers analysis, news and insights across multiple therapy areas and product types. how it works scrip provides business-critical market and company intelligence from our global network of analysts, journalists and key opinion leaders. they cover companies across the industry, from biotech start-ups to multinational giants such as pfizer, sanofi and shire, and report on fields including cardiovascular, diabetes, dermatology, influenza, and oncology. scrip gives you access to the latest licensing opportunities, partnership deals, r&d; activity, market access insights and company developments. your subscription also includes the scrip 100 annual review, which tracks and analyzes the performance of over 600 companies and provides additional insights into pharma industry topics that impact your business. request a free trial what's included below are the feature list follow market developments scrips global team of journalists span key markets around the clock go beyond the news get exclusive access to accurate data, timely insights and trusted analysis that delivers to gain competitive advantage hear from news makers access interviews with leading decision makers, industry experts and thought leaders , across the industry. ask the expert put your questions about any of our news stories, data and analysis to our expert journalists and analysts. pharma intelligence: latest select categories all categories commercial company strategy financing oncology regulation company profile policy cardiovascular digital health drug delivery immunology & inflammation cardiovascular & metabolic in vitro diagnostics legislation metabolic neurology pipeline scrip a plea for patience: bristol nektar's opdivo/nktr-214 combo responses deepen over time by emily hayes 06 jun 2018 the cancer immunotherapy combo showed "remarkable" effects in patients who tested negative for pd-l1 expression and would normally not respond well to immunotherapy. view article scrip asco 2018 optimism as industry resets and looks to what is next by jessica merrill 06 jun 2018 investors weren't wildy impressed by the data at asco this year, but for pharma, the meeting felt like a renewal, a re-commitment to getting it right. it was more a year of refinement as industry digests the advances that have been made, the big mistakes, and pivots toward where to go next. topic cancer view article scrip novo's oral semaglutide passes pioneer 2, but weight loss result a bit disappointing by emily hayes 04 jun 2018 in second phase iii diabetes study to report, oral glp-1 agonist semaglutide misses some weight loss goals when compared with boehringer/lilly's sglt-2 inhibitor jardiance. topic drug approval drug development landscape drug review view article scrip interview almirall ceo guenter plots play to win future by eleanor malone 01 jun 2018 peter guenter has steadied the ship at almirall, and after seven months in the role he outlines his vision for the company in his first exclusive interview as ceo of spain's largest pharma company. topic business strategies company analysis view article citeline, scrip, biomedtracker, datamonitor healthcare asco essentials webinar 2018 recording by loni branon 29 may 2018 just in time for your 2018 asco annual meeting planning, join analysts from datamonitor healthcare, biomedtracker, citeline, scrip, and pink sheet for their expert opinions on what you need to know to get the most from the meeting. let our experts present their top picks from the thousands of abstracts being presented at asco. topic clinical trials full video scrip new chugai ceo lays course as he takes reins by ian haydock 25 may 2018 chugai's new ceo tatsuro kosaka took up his position in march and is charged with taking the major japanese company through the next stage of development as key products reach the global market and others begin to face biosimilar competition. in this first part of a two-part exclusive interview, he outlines the firm's vision, approach to r&d and how the strategic alliance with roche is playing out. topic business strategies research view article scrip remember when provenge's price was bold? every new cancer drug in 2017 cost $100,000 or more by jessica merrill 25 may 2018 the price of new oncology brands doubled in the us from 2013 to 2017, bringing the median annual price to more than $160,000 last year, up from $79,000 in 2013, according to a new iqvia report. spending on cancer drugs in the us has doubled since 2012, reaching nearly $50bn in 2017. topic cancer view article scrip pfizer's three-pronged oncology strategy includes expanding ibrance, xtandi, developing blockbuster combos by brenda sandburg 23 may 2018 xtandi use in early prostate cancer, lorlatinib as second-line treatment for non-small cell lung cancer and dacomitinib for first-line nsclc have upcoming user fee dates. topic cancer view article scrip missing in action: china’s best shot in ebola vaccine race by brian yang 23 may 2018 as the congo grapples with the latest outbreak of ebola, china has approved its first domestically developed vaccine in record time, hailing it a national innovation champion. but as the world health organization starts vaccinations in africa, can china make the cut and compete with global players including merck & co? topic vaccines view article scrip pharma backs uk parliament report as 'no deal brexit' fears grow 18 may 2018 the pharmaceutical sector has given its backing to a report from mps which warns that a no-deal brexit will have a hugely damaging effect on the industry in the country, turning it into "a second-tier state for new and innovative medicines." topic brexit business strategies view article scrip immuno oncology: what to watch at asco 2018 by emily hayes 18 may 2018 cancer immunotherapy is once again set to dominate the upcoming american society of clinical oncology annual meeting, with a continuing showdown for pd-1 inhibitors in lung cancer, a car-t battle, and disappointments for new io classes. topic cancer view article scrip first of its kind: beam seeks to erase-and-replace single letters in dna's alphabet by mandy jackson 16 may 2018 beam therapeutics combines new insights from gene-editing pioneers to allow for single-letter editing of dna and rna. the company has raised $87m to develop dna base-editing for therapies that in some diseases could be more efficient than crispr gene editing. view article scrip newlink ceo reflects on golden age and rapid fall of ido by emily hayes 16 may 2018 there is now a move back to the principle of doing randomized phase ii studies before jumping into phase iii, says ceo chuck link, as roche's genentech exits broad ido/tdo deal. topic cancer view article scrip fda refuse-to-file letter for alkermes depression drug suggests a lengthy commercial delay by jessica merrill 15 may 2018 ceo richard pops called fda's letter for alks 5461 "surprising and troubling." alkermes had been ramping up to launch the depression drug later this year, though some investors had remained skeptical. topic fda drug approval view article scrip from pharma insider to payer: witty to lead united's optum by jessica merrill 15 may 2018 former gsk ceo witty stood out among big pharma chief execs for his pessimistic outlook on us drug pricing, which shaped his diversification strategy at gsk. his experience as a pharma insider makes him an interesting choice to lead united's pbm and health services arm. topic drug review view article latest headlines scrip 12 jun 2018 mehta analysis: takeda and alliancebernstein moves contain a message for pharma link scrip 12 jun 2018 vortioxetine set for japan filing but prospects limited? link scrip 12 jun 2018 lilly/astrazeneca's lanabecestat becomes latest bace inhibitor casualty link scrip 11 jun 2018 new eu approval further boost for tagrisso as threats recede link scrip 11 jun 2018 vical faced with failure of another vaccine trial link scrip 11 jun 2018 migraine drug atogepant delivers good news when allergan needs it most link scrip 11 jun 2018 historic mapping of deadly pathogens allows pacbio to showcase its platform link scrip 11 jun 2018 pipeline watch: phase iii progress with nimotuzumab, solriamfetol, and upadacitinib link scrip 08 jun 2018 cipla opens up to crowd sourcing innovation link scrip 08 jun 2018 novo nordisk seen readying steps to offset us pressures, including job cuts link scrip 08 jun 2018 next-generation roche: how data analytics will keep it in the lead in oncology link scrip 08 jun 2018 on track to approval, alkermes hopes alks-5461 can change future of depression therapy link scrip 08 jun 2018 ipo update: returns rebound as june sees its first new biopharma offering link scrip 08 jun 2018 takeda secures tigenix but investor shire concerns bubble up link scrip 08 jun 2018 nature cell keeps hopes up for jointstem despite conditional approval rejection link meet the team below are the analyst profile editor john hodgson editor, executive editor john specializes in policy & regulation +36 year(s) experience scrip pink sheet profile editor ian schofield editor, executive editor, pharma insights uk ian specializes in policy & regulation clinical trials +33 year(s) experience scrip pink sheet profile reporter-journalist john davis reporter-journalist, senior editor, pharma insights +31 year(s) experience scrip pink sheet profile see all analysts how we've helped other businesses "scrip helps me to stay current with pharmaceutical news on a world-wide basis." ​wendy johnson ​ceo, aires pharmaceuticals, usa "rxscorecard™ provides a comprehensive, multi-pronged rubric assisting us in decision-making as we begin to move from a volume to value drug evaluation methodology." ​chronis h. manolis, rph ​vice president, pharmacy upmc health plan "rxscorecard™ lets a biopharma company anticipate the most important factors impacting the clinical & economic value of pipeline and marketed drugs -- and then helps identify the necessary changes to the clinical development and commercial program to maximize that value for all stakeholders, especially including payers. it's a required, straightforward, objective strategic tool that allows us to quickly and effectively adapt to a rapidly changing and much more challenging market access environment." ​ammar qadan ​global value/market access lead oncology portfolio & global commercial lead oncology biomarkers halozyme therapeutics, inc. related products datamonitor healthcare: data analysis and insight support the development and validation of your strategic plans and ensure commercial decisions are based on marketplace realities. datamonitor healthcare offers expert coverage of key diseases, treatments, companies, drugs, market access and market trends. our primary research with physicians, payers, and kols (key opinion leaders) informs our treatment standards data and patient-based forecasts. view product medtrack: full healthcare business coverage from discovery to patent expiry, and coverage spanning both ethical and generic drugs, medtrack has you covered. stay current on key financing, drug and biologics development and drug manufacturing information, all with a single tool. view product trialtrove: gold standard clinical trials intelligence trialtrove is the go-to resource for clinical trial research. easily track your competitors' clinical r&d activity with expert insights and continually monitored trials. view product view all looking for more products product finder keep up to date 12 jun 2018 pharmascrip attend our webinar on 6/14 @ 11am edt and discover the challenges clinical trial sites face and the technology that… twitter.com/i/web/status/1… 12 jun 2018 pharmascrip sotio aims to become a diverse oncology company cancer vaccine development is not the only r&d avenue being pursued… twitter.com/i/web/status/1… 12 jun 2018 pharmascrip uk charity aims to knock years off lung cancer vaccine development having linked up with asterias, nigel blackburn,… twitter.com/i/web/status/1… 12 jun 2018 pharmascrip new #webinar : disrupting the status quo of #eclinical identity management: removing the burden at clinical trials.… twitter.com/i/web/status/1… 12 jun 2018 pharmascrip join us on june 14th at 11am edt for a webinar sponsored by @almacgroup and @exostar regarding clinical trial site… twitter.com/i/web/status/1… 12 jun 2018 pharmascrip bio notebook day 4: gottlieb seeks early engagement on gene therapy; ireland’s #brexit opportunities; amag’s bremel… twitter.com/i/web/status/1… 12 jun 2018 pharmascrip webinar on 6/14: discover the challenges clinical trial sites face and the technology that has greatly improved the… twitter.com/i/web/status/1… 12 jun 2018 pharmascrip levin calls takeda/shire merger ‘inspired,’ says entire value chain must address pricing issue having previously cr… twitter.com/i/web/status/1… 12 jun 2018 pharmascrip levin calls takeda/shire merger ‘inspired,’ says entire value chain must addressing pricing issue having previously… twitter.com/i/web/status/1… 11 jun 2018 pharmascrip new eu approval further boost for tagrisso as threats recede tagrisso's march on the first-line egfrm nsclc market… twitter.com/i/web/status/1… 11 jun 2018 pharmascrip bio notebook day 2: levin scolds industry for squandering proceeds from us tax reform: bit.ly/2heyxei … twitter.com/i/web/status/1… 11 jun 2018 pharmascrip biosimilar antitrust pressure on @jnjnews grows as walgreen, kroger sue over remicade contracts:… twitter.com/i/web/status/1… 11 jun 2018 pharmascrip the 14th annual scrip awards, entry deadline is fast approaching. submit your nominations before 15 june!… twitter.com/i/web/status/1… 11 jun 2018 pharmascrip is there a new strategic asian pharma partnership in the works? early days perhaps but worth keeping an eye on the… twitter.com/i/web/status/1… next steps this is contactus section request a trial whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments. request a free trial how can we help you? our team is always happy to hear from you. please call us at: us toll-free : +1 888 670 8900 us toll : +1 908 547 2200 uk & europe : +44 (20) 337 73737 australia : +61 2 8705 6907 japan : +81 3 6273 4260 or please submit your inquiry via the form so that we can provide you the best possible customer service. general enquiry pharma report store have an immediate and specific information need? browse and buy from 1000s of analysis and research reports now: shop now × thank you for requesting a trial we have received your request and we will get back to you soon. oops, there appears to be a problem request a trial for country united states united kingdom afghanistan aland islands albania algeria american samoa andorra angola anguilla antarctica antigua and barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia, plurinational state of bonaire, sint eustatius and saba bosnia and herzegovina botswana bouvet island brazil british indian ocean territory brunei darussalam bulgaria burkina faso burundi caboverde cambodia cameroon canada cayman islands central african republic chad chile china christmas island cocos (keeling) islands colombia comoros congo congo, the democratic republic of the cook islands costa rica cote d'ivoire croatia cuba curaçao cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt elsalvador equatorial guinea eritrea estonia ethiopia falkland islands (malvinas) faroe islands fiji finland france french guiana french polynesia french southern territories gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guernsey guinea guinea-bissau guyana haiti heard islandand mcdonald islands holysee (vatican city state) honduras hongkong hungary iceland india indonesia iran (islamic republic of) iraq ireland isle of man israel italy jamaica japan jersey jordan kazakhstan kenya kiribati korea(democratic people's republic of) korea(republic of) kuwait kyrgyzstan lao people's democratic republic latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia the former yugoslav republic of madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte mexico micronesia moldova republic of monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands new caledonia new zealand nicaragua niger nigeria niue norfolk island northern mariana islands norway oman pakistan palau palestine panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint barthélemy saint helena, ascension and tristan da cun saint kitts and nevis saint lucia saint martin (french part) saint pierre and miquelon saint vincent and the grenadines samoa sanmarino sao tome and principe saudi arabia senegal serbia seych elles sierraleone singapore sint maarten(dutchpart) slovakia slovenia solomon islands somalia south africa south georgia and the south sandwich islands south sudan spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syrian arab republic taiwan tajikistan tanzania, united republic of thailand timor-leste togo tokelau tonga trinidad and tobago tunisia turkey turkmenistan turksand caicos islands tuvalu uganda ukraine united states minor outlying islands united arab emirates uruguay uzbekistan vanuatu venezuela, bolivarian republic of vietnam virgin islands (british) virgin islands (u.s.) wallis and futuna western sahara yemen zambia zimbabwe please provide a valid email address. products scrip tc existing customer i am an existing customer of informa terms and conditions by ticking this box, you agree to receive emails such as promotional offers from other members of the informa group and selected 3rd party companies additional fields by ticking this box, you agree to receive emails such as relevant news, updates and offers from pharma intelligence , and carefully selected similar products from our portfolio verticalname formname eloquacustomerguid eloquacookiewrite failureemailtoaddress secondarytitle clientid utmsource utmmedium utmcampaign utmterm utmcontent landingpageurl informa privacy policy informa terms & conditions × thank you for requesting a demo we have received your request and we will get back to you soon. oops, there appears to be a problem request a demo for country united states united kingdom afghanistan aland islands albania algeria american samoa andorra angola anguilla antarctica antigua and barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia, plurinational state of bonaire, sint eustatius and saba bosnia and herzegovina botswana bouvet island brazil british indian ocean territory brunei darussalam bulgaria burkina faso burundi caboverde cambodia cameroon canada cayman islands central african republic chad chile china christmas island cocos (keeling) islands colombia comoros congo congo, the democratic republic of the cook islands costa rica cote d'ivoire croatia cuba curaçao cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt elsalvador equatorial guinea eritrea estonia ethiopia falkland islands (malvinas) faroe islands fiji finland france french guiana french polynesia french southern territories gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guernsey guinea guinea-bissau guyana haiti heard islandand mcdonald islands holysee (vatican city state) honduras hongkong hungary iceland india indonesia iran (islamic republic of) iraq ireland isle of man israel italy jamaica japan jersey jordan kazakhstan kenya kiribati korea(democratic people's republic of) korea(republic of) kuwait kyrgyzstan lao people's democratic republic latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia the former yugoslav republic of madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte mexico micronesia moldova republic of monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands new caledonia new zealand nicaragua niger nigeria niue norfolk island northern mariana islands norway oman pakistan palau palestine panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint barthélemy saint helena, ascension and tristan da cun saint kitts and nevis saint lucia saint martin (french part) saint pierre and miquelon saint vincent and the grenadines samoa sanmarino sao tome and principe saudi arabia senegal serbia seych elles sierraleone singapore sint maarten(dutchpart) slovakia slovenia solomon islands somalia south africa south georgia and the south sandwich islands south sudan spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syrian arab republic taiwan tajikistan tanzania, united republic of thailand timor-leste togo tokelau tonga trinidad and tobago tunisia turkey turkmenistan turksand caicos islands tuvalu uganda ukraine united states minor outlying islands united arab emirates uruguay uzbekistan vanuatu venezuela, bolivarian republic of vietnam virgin islands (british) virgin islands (u.s.) wallis and futuna western sahara yemen zambia zimbabwe please provide a valid email address. products scrip tc existing customer i am an existing customer of informa terms and conditions by ticking this box, you agree to receive emails such as promotional offers from other members of the informa group and selected 3rd party companies additional fields by ticking this box, you agree to receive emails such as relevant news, updates and offers from pharma intelligence , and carefully selected similar products from our portfolio verticalname formname eloquacustomerguid eloquacookiewrite failureemailtoaddress secondaytitle clientid utmsource utmmedium utmcampaign utmterm utmcontent landingpageurl informa privacy policy informa terms & conditions × register for free content after submitting your details, you will have access to all content resources available on this website please provide a valid email address. country united states united kingdom afghanistan aland islands albania algeria american samoa andorra angola anguilla antarctica antigua and barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia, plurinational state of bonaire, sint eustatius and saba bosnia and herzegovina botswana bouvet island brazil british indian ocean territory brunei darussalam bulgaria burkina faso burundi caboverde cambodia cameroon canada cayman islands central african republic chad chile china christmas island cocos (keeling) islands colombia comoros congo congo, the democratic republic of the cook islands costa rica cote d'ivoire croatia cuba curaçao cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt elsalvador equatorial guinea eritrea estonia ethiopia falkland islands (malvinas) faroe islands fiji finland france french guiana french polynesia french southern territories gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guernsey guinea guinea-bissau guyana haiti heard islandand mcdonald islands holysee (vatican city state) honduras hongkong hungary iceland india indonesia iran (islamic republic of) iraq ireland isle of man israel italy jamaica japan jersey jordan kazakhstan kenya kiribati korea(democratic people's republic of) korea(republic of) kuwait kyrgyzstan lao people's democratic republic latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia the former yugoslav republic of madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte mexico micronesia moldova republic of monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands new caledonia new zealand nicaragua niger nigeria niue norfolk island northern mariana islands norway oman pakistan palau palestine panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint barthélemy saint helena, ascension and tristan da cun saint kitts and nevis saint lucia saint martin (french part) saint pierre and miquelon saint vincent and the grenadines samoa sanmarino sao tome and principe saudi arabia senegal serbia seych elles sierraleone singapore sint maarten(dutchpart) slovakia slovenia solomon islands somalia south africa south georgia and the south sandwich islands south sudan spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syrian arab republic taiwan tajikistan tanzania, united republic of thailand timor-leste togo tokelau tonga trinidad and tobago tunisia turkey turkmenistan turksand caicos islands tuvalu uganda ukraine united states minor outlying islands united arab emirates uruguay uzbekistan vanuatu venezuela, bolivarian republic of vietnam virgin islands (british) virgin islands (u.s.) wallis and futuna western sahara yemen zambia zimbabwe products biomedtracker chinatrove citeline citeline analytics citeline user access clinical and research excellence commercial optimization solutions datamonitor healthcare in vivo marketing services: lead generation marketing services: awareness marketing services: network in person marketing services: our popular solutions marketing services: our products and audiences marketing services: thought leadership meddevicetracker medtech insight medtrack pharma consulting pharmapremia pharmaprojects pink sheet portfolio management solutions research and development strategy solutions rose sheet rxscorecard scrip sitetrove strategic transactions trialtrove tems and conditions by ticking this box, you agree to receive emails such as promotional offers from other members of the informa group and selected 3rd party companies additional fields by ticking this box, you agree to receive emails such as relevant news, updates and offers from pharma intelligence , and carefully selected similar products from our portfolio redirecturl formname verticalname eloquacustomerguid failureemailtoaddress clientid eloquacookiewrite utmsource utmmedium utmcampaign utmterm utmcontent landingpageurl informa privacy policy informa terms & conditions × thank you for requesting a trial we have received your request and we will get back to you soon. oops, there appears to be a problem request a trial for country united states united kingdom afghanistan aland islands albania algeria american samoa andorra angola anguilla antarctica antigua and barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia, plurinational state of bonaire, sint eustatius and saba bosnia and herzegovina botswana bouvet island brazil british indian ocean territory brunei darussalam bulgaria burkina faso burundi caboverde cambodia cameroon canada cayman islands central african republic chad chile china christmas island cocos (keeling) islands colombia comoros congo congo, the democratic republic of the cook islands costa rica cote d'ivoire croatia cuba curaçao cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt elsalvador equatorial guinea eritrea estonia ethiopia falkland islands (malvinas) faroe islands fiji finland france french guiana french polynesia french southern territories gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guernsey guinea guinea-bissau guyana haiti heard islandand mcdonald islands holysee (vatican city state) honduras hongkong hungary iceland india indonesia iran (islamic republic of) iraq ireland isle of man israel italy jamaica japan jersey jordan kazakhstan kenya kiribati korea(democratic people's republic of) korea(republic of) kuwait kyrgyzstan lao people's democratic republic latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia the former yugoslav republic of madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte mexico micronesia moldova republic of monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands new caledonia new zealand nicaragua niger nigeria niue norfolk island northern mariana islands norway oman pakistan palau palestine panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint barthélemy saint helena, ascension and tristan da cun saint kitts and nevis saint lucia saint martin (french part) saint pierre and miquelon saint vincent and the grenadines samoa sanmarino sao tome and principe saudi arabia senegal serbia seych elles sierraleone singapore sint maarten(dutchpart) slovakia slovenia solomon islands somalia south africa south georgia and the south sandwich islands south sudan spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syrian arab republic taiwan tajikistan tanzania, united republic of thailand timor-leste togo tokelau tonga trinidad and tobago tunisia turkey turkmenistan turksand caicos islands tuvalu uganda ukraine united states minor outlying islands united arab emirates uruguay uzbekistan vanuatu venezuela, bolivarian republic of vietnam virgin islands (british) virgin islands (u.s.) wallis and futuna western sahara yemen zambia zimbabwe please provide a valid email address. products scrip tc existing customer i am an existing customer of informa terms and conditions by ticking this box, you agree to receive emails such as promotional offers from other members of the informa group and selected 3rd party companies additional fields by ticking this box, you agree to receive emails such as relevant news, updates and offers from pharma intelligence , and carefully selected similar products from our portfolio verticalname formname eloquacustomerguid eloquacookiewrite failureemailtoaddress secondarytitle clientid utmsource utmmedium utmcampaign utmterm utmcontent landingpageurl informa privacy policy informa terms & conditions × thanks for getting in touch we have received your request and we will get back to you soon. oops, there appears to be a problem general enquiry country united states united kingdom afghanistan aland islands albania algeria american samoa andorra angola anguilla antarctica antigua and barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia, plurinational state of bonaire, sint eustatius and saba bosnia and herzegovina botswana bouvet island brazil british indian ocean territory brunei darussalam bulgaria burkina faso burundi caboverde cambodia cameroon canada cayman islands central african republic chad chile china christmas island cocos (keeling) islands colombia comoros congo congo, the democratic republic of the cook islands costa rica cote d'ivoire croatia cuba curaçao cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt elsalvador equatorial guinea eritrea estonia ethiopia falkland islands (malvinas) faroe islands fiji finland france french guiana french polynesia french southern territories gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guernsey guinea guinea-bissau guyana haiti heard islandand mcdonald islands holysee (vatican city state) honduras hongkong hungary iceland india indonesia iran (islamic republic of) iraq ireland isle of man israel italy jamaica japan jersey jordan kazakhstan kenya kiribati korea(democratic people's republic of) korea(republic of) kuwait kyrgyzstan lao people's democratic republic latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia the former yugoslav republic of madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte mexico micronesia moldova republic of monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands new caledonia new zealand nicaragua niger nigeria niue norfolk island northern mariana islands norway oman pakistan palau palestine panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint barthélemy saint helena, ascension and tristan da cun saint kitts and nevis saint lucia saint martin (french part) saint pierre and miquelon saint vincent and the grenadines samoa sanmarino sao tome and principe saudi arabia senegal serbia seych elles sierraleone singapore sint maarten(dutchpart) slovakia slovenia solomon islands somalia south africa south georgia and the south sandwich islands south sudan spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syrian arab republic taiwan tajikistan tanzania, united republic of thailand timor-leste togo tokelau tonga trinidad and tobago tunisia turkey turkmenistan turksand caicos islands tuvalu uganda ukraine united states minor outlying islands united arab emirates uruguay uzbekistan vanuatu venezuela, bolivarian republic of vietnam virgin islands (british) virgin islands (u.s.) wallis and futuna western sahara yemen zambia zimbabwe please provide a valid email address. products biomedtracker chinatrove citeline citeline analytics citeline user access clinical and research excellence commercial optimization solutions datamonitor healthcare in vivo marketing services: lead generation marketing services: awareness marketing services: network in person marketing services: our popular solutions marketing services: our products and audiences marketing services: thought leadership meddevicetracker medtech insight medtrack pharma consulting pharmapremia pharmaprojects pink sheet portfolio management solutions research and development strategy solutions rose sheet rxscorecard scrip sitetrove strategic transactions trialtrove terms and conditions i am an existing customer of informa by ticking this box, you agree to receive emails such as promotional offers from other members of the informa group and selected 3rd party companies additional fields by ticking this box, you agree to receive emails such as relevant news, updates and offers from pharma intelligence , and carefully selected similar products from our portfolio verticalname formname eloquacookiewrite eloquacustomerguid failureemailtoaddress clientid utmsource utmmedium utmcampaign utmterm utmcontent landingpageurl informa privacy policy informa terms & conditions more from informa business intelligence: financial intelligence maritime intelligence professional services tmt intelligence agribusiness intelligence pharma intelligence social networks get the latest follow our stories watch our stories connect with us home privacy policy terms and conditions sitemap cookie policy contact us trial investigators privacy notice copyright © 2018 informa plc informa uk limited is a company registered in england and wales with company number 1072954 whose registered office is 5 howick place, london, sw1p 1wg. vat gb365462636. informa uk limited is part of informa plc. ×

URL analysis for scripclinicalresearch.com

https://pharmaintelligence.informa.com/products-and-services/news-and-insights/scrip/about/meet-the-team/john-hodgson
https://pharmaintelligence.informa.com/products-and-services/news-and-insights/scrip/cookie-policy-page
https://scrip.pharmaintelligence.informa.com/sc123231/nextgeneration%20roche%20how%20data%20analytics%20will%20keep%20it%20in%20the%20lead%20in%20oncology?utm_source=search&utm_medium=rss&utm_term=&utm_campaign=search_rss
https://pharmaintelligence.informa.com/products-and-services/news-and-insights/scrip/products-and-services/data-and-analysis/biomedtracker
https://pharmaintelligence.informa.com/products-and-services/news-and-insights/scrip/resources/key-topics/immuno-oncology
https://pharmaintelligence.informa.com/products-and-services/news-and-insights/scrip/products-and-services/data-and-analysis/datamonitor-healthcare
https://pharmaintelligence.informa.com/products-and-services/news-and-insights/scrip/products-and-services/news-and-insights/in-vivo
https://pharmaintelligence.informa.com/products-and-services/news-and-insights/scrip/who-we-help/who/pharmaceutical-companies
https://pharmaintelligence.informa.com/products-and-services/news-and-insights/scrip/product-listing
https://pharmaintelligence.informa.com/products-and-services/news-and-insights/scrip/resources/key-topics/cell-and-gene-therapy
https://pharmaintelligence.informa.com/products-and-services/news-and-insights/scrip/events/awards/medtech-insight-awards-2018
https://pharmaintelligence.informa.com/products-and-services/news-and-insights/scrip/resources/thought-leadership/case-study
https://pharmaintelligence.informa.com/products-and-services/news-and-insights/scrip/resources/key-topics/fda
https://pharmaintelligence.informa.com/products-and-services/news-and-insights/scrip/events/awards/scrip-awards-2018
https://pharmaintelligence.informa.com/products-and-services/news-and-insights/scrip/products-and-services/data-and-analysis/medtrack

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: SCRIPCLINICALRESEARCH.COM
Registry Domain ID: 1570773250_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.safenames.net
Registrar URL: http://www.safenames.net
Updated Date: 2016-10-01T09:21:07Z
Creation Date: 2009-09-30T07:46:10Z
Registry Expiry Date: 2018-09-30T07:46:10Z
Registrar: SafeNames Ltd
Registrar IANA ID: 447
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: DNS1.IDP365.NET
Name Server: DNS2.IDP365.NET
Name Server: DNS3.IDP365.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-08-10T09:43:24Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR SafeNames Ltd

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =scripclinicalresearch.com

  PORT 43

  TYPE domain

DOMAIN

  NAME scripclinicalresearch.com

  CHANGED 2016-10-01

  CREATED 2009-09-30

STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

NSERVER

  DNS1.IDP365.NET 217.19.248.20

  DNS2.IDP365.NET 31.3.66.150

  DNS3.IDP365.NET 207.228.239.80

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .